USA-based Madrigal Pharmaceuticals today announced that it has entered into an exclusive global license agreement with CSPC ...

Swiss pharma company Idorsia today released encouraging first half 2025 financial results, sending its shares up 8.5% to 2.94 ...

LTZ Therapeutics, a Sino-American biotech focused on immunotherapy, has announced a strategic research collaboration with US ...

Germany’s Evotec today announced a non-binding agreement with Switzerland’s Sandoz regarding the potential sale of Just – ...

Shares of DURECT Corporation shot up 240% to $1.88 by close of trading Tuesday, after Canada’s Bausch Health agreed to ...

Japanese drugmaker Eisai revealed that its in-house discovered tyrosine kinase inhibitor, Lenvima (lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial ...

US AI-focused start-up Formation Bio and IMIDomics, a precision medicine company focused on immune-mediated inflammatory diseases today announced that Formation Bio has licensed worldwide rights to ...

US pharma giant Pfizer has criticized the recent inclusion of the company in the list of enterprises that should be denied ...

Artbio, a US biotech specializing in radiopharmaceuticals, has raised $132 million in a series B financing to move its lead ...

A major US trial has found that structured healthy lifestyle programs can slow memory loss in older adults, regardless of ...

A new real-world analysis from UK drugmaker Indivior (Nasdaq: INDV) suggests that patients with opioid use disorder (OUD) ...

Eli Lilly today announced positive top-line results from the Phase III BRUIN CLL-314 clinical trial of Jaypirca ...